1 BREO ELLIPTA (FLUTICASONE/VILANTEROL) | 20 of 270 | 1210 prescriptions Less than 1% of all prescriptions | | 220 patients 12% of all patients | < 11 | |
2 ADVAIR DISKUS (FLUTICASONE PROPION/SALMETEROL) | 30 of 310 | 850 prescriptions Less than 1% of all prescriptions | | 240 patients 13% of all patients | < 11 | |
3 MONTELUKAST SODIUM | 100 of 320 | 510 prescriptions Less than 1% of all prescriptions | | 140 patients 7% of all patients | < 11 | |
4 SYMBICORT (BUDESONIDE/FORMOTEROL FUMARATE) | 120 of 380 | 540 prescriptions Less than 1% of all prescriptions | | 200 patients 11% of all patients | < 11 | |
5 ANORO ELLIPTA (UMECLIDINIUM BRM/VILANTEROL TR) | 30 of 250 | 790 prescriptions Less than 1% of all prescriptions | 790 | 130 patients 7% of all patients | 130 patients 7% of all patients | |
6 FLUTICASONE PROPIONATE | 30 of 220 | 670 prescriptions Less than 1% of all prescriptions | | 280 patients 15% of all patients | < 11 | |
7 SPIRIVA (TIOTROPIUM BROMIDE) | 120 of 370 | 490 prescriptions Less than 1% of all prescriptions | 490 | 110 patients 6% of all patients | 110 patients 6% of all patients | |
8 PROAIR HFA (ALBUTEROL SULFATE) | 70 of 320 | 430 prescriptions Less than 1% of all prescriptions | 430 | 350 patients 18% of all patients | 350 patients 18% of all patients | |
9 VENTOLIN HFA (ALBUTEROL SULFATE) | 60 of 310 | 560 prescriptions Less than 1% of all prescriptions | | 370 patients 19% of all patients | < 11 | |
10 SPIRIVA RESPIMAT (TIOTROPIUM BROMIDE) | 120 of 250 | 310 prescriptions Less than 1% of all prescriptions | 310 | < 11 | < 11 | |
11 PREDNISONE | 80 of 390 | 610 prescriptions Less than 1% of all prescriptions | 610 | 300 patients 16% of all patients | 300 patients 16% of all patients | |
12 FUROSEMIDE | 80 of 100 | 180 prescriptions Less than 1% of all prescriptions | 180 | < 11 | < 11 | |
13 INCRUSE ELLIPTA (UMECLIDINIUM BROMIDE) | 90 of 200 | 240 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
14 FLOVENT HFA (FLUTICASONE PROPIONATE) | 40 of 130 | 200 prescriptions Less than 1% of all prescriptions | 200 | < 11 | < 11 | |
15 COMBIVENT RESPIMAT (IPRATROPIUM/ALBUTEROL SULFATE) | 70 of 110 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
16 ARNUITY ELLIPTA (FLUTICASONE FUROATE) | 40 of 120 | 210 prescriptions Less than 1% of all prescriptions | 210 | < 11 | < 11 | |
17 POTASSIUM CHLORIDE | 50 of 70 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
18 TRELEGY ELLIPTA (FLUTICASONE/UMECLIDIN/VILANTER) | 40 of 50 | 160 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
19 AZITHROMYCIN | 260 of 330 | 150 prescriptions Less than 1% of all prescriptions | | 110 patients 6% of all patients | < 11 | A |